Search

everythinglearnresearchcommunity

for

Search:↓

These medications for BPH have known risks and may have new side effects.

These medications for BPH have known risks and may have new side effects.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

Finasteride for hair loss in young men may significantly increase the risk of sexual dysfunction.

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

Finasteride for hair loss in young men increases the risk of sexual dysfunction.

Low-dose finasteride may increase erectile dysfunction risk over time.

Long-term finasteride use may lower prostate cancer risk but increase the need for erectile dysfunction medication.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Young men taking finasteride for hair loss have a higher risk of sexual dysfunction.

Finasteride may be a promising treatment for recurrent priapism in sickle cell anemia.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Finasteride alone increases suicide risk, but combining it with other treatments reduces this risk.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

Udenafil may help hair grow by activating certain stem cells.

Doxazosin and finasteride negatively affect sexual function in men with BPH.

Drugs like PDEI may help hair disorders like AGA.

Ultrasound shows 96% of young men with erectile dysfunction after using finasteride have abnormal penile tissue.

Current treatments for recurrent ischemic priapism are not well-defined and need more research.

The Princeton III Consensus recommends assessing cardiovascular risk in men with erectile dysfunction and prioritizing heart health before treating ED, especially in those with potential heart disease.

Regulatory challenges make developing combination therapies in urology difficult and costly.

Finasteride and SSRIs together increase impotence and low libido risk in men.

The new microneedle treatment could be a more effective and convenient option for hair loss.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.